Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447 | Director · Chief Executive Officer | June 01, 2023 | June 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date June 01, 2023 · Filed June 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 276,096 |
Ending reported balance
After 2023-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-06-01 · Grant · Acquired 150,000 · Balance 201,096 F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2: Restricted Stock Units will vest on the 3rd anniversary of the grant date. Row 2 · 2023-06-01 · Grant · Acquired 75,000 · Balance 276,096 F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F3: Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2: Restricted Stock Units will vest on the 3rd anniversary of the grant date.
F3: Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2023 Filed Jun 5, 2023 19:27 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020841 · wk-form4_1685993261.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,096 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F3 · price: Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 19:27 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020841 · wk-form4_1685993261.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,096 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Restricted Stock Units will vest on the 3rd anniversary of the grant date. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 45,000 | $11.31 | $508,950.00 |
DisclosureSEC source: 0001628280-22-022949 · wf-form4_166060352143970.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 150,000 | $11.31 Strike: $11.31 | $1,696,500.00 |
DisclosureSEC source: 0001628280-22-022949 · wf-form4_166060352143970.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-08-11 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | $10.42 | $104,200.00 |
DisclosureSEC source: 0001628280-22-021699 · wf-form4_166000334579496.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on August 5, 2019. F3 · derivative.exercise_date: The restricted stock units vested on August 5, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 3,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-021699 · wf-form4_166000334579496.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,096 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 00:02 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 10,000 | $10.42 | $104,200.00 |
DisclosureSEC source: 0001628280-22-021699 · wf-form4_166000334579496.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,156 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 21:00 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 49,755 | $0.00 Strike: $9.76 | $0.00 |
DisclosureSEC source: 0001628280-22-019061 · wf-form4_165817799678454.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,755 Underlying: Common Stock · 49,755 shares Expires 2029-07-14 Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 21:00 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (Right to Buy) · Derivative | 10,245 | $0.00 Strike: $9.76 | $0.00 |
DisclosureSEC source: 0001628280-22-019061 · wf-form4_165817799678454.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,245 Underlying: Common Stock · 10,245 shares Expires 2029-07-14 Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 22:12 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified StockOption (right to buy) · Derivative | 66,763 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001593968-21-001897 · primary_01.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,763 Underlying: Common Stock · 66,763 shares Expires 2028-07-27 Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 22:12 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (right to buy) · Derivative | 8,237 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001593968-21-001897 · primary_01.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,237 Underlying: Common Stock · 8,237 shares Expires 2028-07-27 Read SEC document |
| July 25, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · derivative · entry 5 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,625 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on July 25, 2018. F3 · derivative.exercise_date: The restricted stock units vested on July 25, 2021. F3 · derivative.expiration_date: The restricted stock units vested on July 25, 2021. Read SEC document |
| July 25, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,565 | $11.82 | $30,318.30 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · nonDerivative · entry 4 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,156 Read SEC document |
| July 25, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,625 | $11.82 | $66,487.50 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · nonDerivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 3,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · derivative · entry 6 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,574 shares Expires 2021-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · shares: The restricted stock units were granted on July 23, 2020. F5 · derivative.exercise_date: The restricted stock units vested on July 23, 2021. F5 · derivative.expiration_date: The restricted stock units vested on July 23, 2021. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 1,629 | $11.82 | $19,254.78 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,096 Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 19:33 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 3,574 | $11.82 | $42,244.68 |
DisclosureSEC source: 0001593968-21-001872 · primary_01.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 21:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 10,000 | $10.62 | $106,200.00 |
DisclosureSEC source: 0001593968-21-001117 · primary_01.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,151 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.57 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 23:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (Right to Buy) · Derivative | 7,636 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001593968-20-001669 · primary_01.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,636 Underlying: Common Stock · 7,636 shares Expires 2027-07-23 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 23:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 44,864 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001593968-20-001669 · primary_01.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,864 Underlying: Common Stock · 44,864 shares Expires 2027-07-23 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 23:58 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 3,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001669 · primary_01.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,574 Underlying: Common Stock · 3,574 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 3rd anniversary of July 23,2020 and will be automatically settled in shares of common stock. Read SEC document |
| July 23, 2020 Filed Jul 28, 2020 20:43 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (Right to Buy) · Derivative | 7,636 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001593968-20-001673 · primary_01.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,636 Underlying: Common Stock · 7,636 shares Expires 2027-07-23 Read SEC document |
| July 23, 2020 Filed Jul 28, 2020 20:43 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 44,864 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001593968-20-001673 · primary_01.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,864 Underlying: Common Stock · 44,864 shares Expires 2027-07-23 Read SEC document |
| July 23, 2020 Filed Jul 28, 2020 20:43 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 3,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-001673 · primary_01.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,574 Underlying: Common Stock · 3,574 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of July 23,2020 and will be automatically settled in shares of common stock. Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 23:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-009006 · wf-form4_159131213988724.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2020-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on June 1, 2020. F3 · derivative.expiration_date: The restricted stock units vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 23:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 7,606 | $10.84 | $82,449.04 |
DisclosureSEC source: 0001628280-20-009006 · wf-form4_159131213988724.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,151 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 23:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 25,000 | $10.84 | $271,000.00 |
DisclosureSEC source: 0001628280-20-009006 · wf-form4_159131213988724.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 00:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (Right to Buy) · Derivative | 17,900 | $10.12 Strike: $10.12 | $181,148.00 |
DisclosureSEC source: 0001628280-20-000195 · wf-form4_157853085657251.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 17,900 shares Expires 2027-01-07 Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 00:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 82,100 | $10.12 Strike: $10.12 | $830,852.00 |
DisclosureSEC source: 0001628280-20-000195 · wf-form4_157853085657251.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100 Underlying: Common Stock · 82,100 shares Expires 2027-01-07 Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 20:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-010121 · wf-form4_156512187725382.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2019 Filed May 28, 2019 21:45 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007270 · wf-form4_155907993668187.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2019. Read SEC document |
| May 25, 2019 Filed May 28, 2019 21:45 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 1,511 | $9.42 | $14,233.62 |
DisclosureSEC source: 0001628280-19-007270 · wf-form4_155907993668187.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,757 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 25, 2019 Filed May 28, 2019 21:45 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $9.42 | $47,100.00 |
DisclosureSEC source: 0001628280-19-007270 · wf-form4_155907993668187.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007124 · wf-form4_155863105154094.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2019-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted July 25, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 22, 2019. Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,207 | $9.66 | $21,319.62 |
DisclosureSEC source: 0001628280-19-007124 · wf-form4_155863105154094.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,268 Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 7,000 | $9.66 | $67,620.00 |
DisclosureSEC source: 0001628280-19-007124 · wf-form4_155863105154094.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 3,282 | $14.35 Strike: $14.35 | $47,096.70 |
DisclosureSEC source: 0001437749-18-013905 · rdgdoc.xml · derivative · entry 5 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,875 Underlying: Common Stock · 3,282 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonqualified Stock Option (Right to Buy) · Derivative | 13,593 | $14.35 Strike: $14.35 | $195,059.55 |
DisclosureSEC source: 0001437749-18-013905 · rdgdoc.xml · derivative · entry 4 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,593 Underlying: Common Stock · 13,593 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 9,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-013905 · rdgdoc.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,045 Underlying: Common Stock · 9,045 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F4 · derivative.exercise_date: Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-013905 · rdgdoc.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2019-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.exercise_date: Restricted Stock Units will vest in 10 months as this is a special grant given to this individual as approved by the Board of Directors. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 5,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-013905 · rdgdoc.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 5,625 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010760 · rdgdoc.xml · derivative · entry 3 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 1,525 | $13.65 | $20,816.25 |
DisclosureSEC source: 0001437749-18-010760 · rdgdoc.xml · nonDerivative · entry 2 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,475 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,000 | $13.65 | $68,250.00 |
DisclosureSEC source: 0001437749-18-010760 · rdgdoc.xml · nonDerivative · entry 1 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010677 · rdgdoc.xml · derivative · entry 2 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.expiration_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:37 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 75,000 | $14.00 Strike: $14.00 | $1,050,000.00 |
DisclosureSEC source: 0001437749-17-010677 · rdgdoc.xml · derivative · entry 1 Hall James G · CIK 0001368626 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/36 of the grant becomes exercisable on each monthly anniversary of the grant date, June 1, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.